Subject of Alkermes-Janssen collaboration revealed; compound advancing to phase III trials April 23, 1999
Antisense oligonucleotide against alpha4 integrin improves paralysis in animal model of MS April 23, 1999
Aminomethyl benzofuran-based compounds as potent and selective 5-HT1A receptor ligands April 22, 1999
DuPont patents new series for suppressing CRF hypersecretion and/or treating anxiogenic disorders April 21, 1999
RSS